|
GB0911042D0
|
|
Treatment of tumorigenic cells in solid tumours
|
|
GB0908952D0
|
|
Antiviral therapy
|
|
GB0819857D0
|
|
Antiviral therapy
|
|
GB0818356D0
|
|
Antibodies
|
|
GB0813352D0
|
|
Cancer treatment and test
|
|
GB0804501D0
|
|
Cellular differentiation promotion
|
|
GB0720136D0
|
|
Treatment of blood disorded
|
|
GB0707208D0
|
|
Novel disease treatments
|
|
GB0624500D0
|
|
A novel passive vaccine for candida infections
|
|
GB0624302D0
|
|
Micro RNA
|
|
GB0624301D0
|
|
Micro RNA
|
|
GB0506797D0
|
|
Treatment of cognitive and learning impairment
|
|
GB0409774D0
|
|
Diagnostic tests for SARS and kits therefor
|
|
GB0406389D0
|
|
Recombinant herpes simplex virus and uses therefor
|
|
GB0405657D0
|
|
Recombinant herpes simplex virus and uses therefor
|
|
GB0405480D0
|
|
Novel tat complexes,and vaccines comprising them
|
